Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityFed Funds SoldGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLoansLoans - NetLong-Term Deferred TaxNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsSecurities - TradableSecurities BoughtShareholder's EquityShares OutstandingTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Business First Bancshares (BFST) Shares Outstanding (2016 - 2025)

Business First Bancshares has reported Shares Outstanding over the past 10 years, most recently at $29.5 million for Q4 2025.

  • Quarterly results put Shares Outstanding at $29.5 million for Q4 2025, changed 0.14% from a year ago — trailing twelve months through Dec 2025 was $29.5 million (changed 0.14% YoY), and the annual figure for FY2025 was $29.5 million, changed 0.14%.
  • Shares Outstanding for Q4 2025 was $29.5 million at Business First Bancshares, roughly flat from $29.6 million in the prior quarter.
  • Over the last five years, Shares Outstanding for BFST hit a ceiling of $29.6 million in Q3 2025 and a floor of $2.6 million in Q3 2022.
  • Median Shares Outstanding over the past 5 years was $25.3 million (2023), compared with a mean of $24.0 million.
  • Biggest five-year swings in Shares Outstanding: plummeted 87.22% in 2022 and later surged 872.85% in 2023.
  • Business First Bancshares' Shares Outstanding stood at $20.4 million in 2021, then increased by 23.09% to $25.1 million in 2022, then rose by 0.96% to $25.4 million in 2023, then increased by 16.57% to $29.6 million in 2024, then fell by 0.14% to $29.5 million in 2025.
  • The last three reported values for Shares Outstanding were $29.5 million (Q4 2025), $29.6 million (Q3 2025), and $29.6 million (Q2 2025) per Business Quant data.